Ramirez Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-200
Closed -$58.5K 360
2026
Q1
$58.5K Sell
200
-150
-43% -$49.3K 0.01% 243
2025
Q4
$123K Hold
350
0.02% 238
2025
Q3
$113K Sell
350
-3,299
-90% -$1.03M 0.02% 238
2025
Q2
$1.42M Buy
3,649
+3,238
+788% +$1.3M 0.21% 123
2025
Q1
$179K Hold
411
0.04% 206
2024
Q4
$152K Buy
411
+400
+3,636% +$167K 0.03% 220
2024
Q3
$5.72K Hold
11
﹤0.01% 380
2024
Q2
$5.96K Hold
11
﹤0.01% 375
2024
Q1
$5.7K Hold
11
﹤0.01% 368
2023
Q4
$5.19K Hold
11
﹤0.01% 361
2023
Q3
$4.79K Buy
+11
New +$4.99K ﹤0.01% 366

Other funds holding ELV

Ramirez Asset Management's ELV Position: Q2 2026 in Review

Ramirez Asset Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 200 shares — an estimated $58.5K sold.

Ramirez Asset Management first reported a position in ELV in Q3 2023 and held it in 11 quarters. The position peaked at $1.42M in Q2 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ramirez Asset Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Ramirez Asset Management sold 200 Elevance Health shares in Q2 2026, an estimated $58.5K.
  • Ramirez Asset Management first reported a position in Elevance Health in Q3 2023 and held it in 11 quarters.
  • Ramirez Asset Management's Elevance Health position peaked at $1.42M in Q2 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ramirez Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.